MErCuRIC researchers from RCSI, BHSCT, QUB and PDUM presented results from their other research projects in colorectal cancer at the American Society of Clinical Oncology (ASCO) 2016 Annual meeting in Chicago, 03 – 07 June. A systems model of BCL-2 dependent apoptosis to predict stage II CRC patients benefiting from adjuvant chemotherapy and as a […]
This author has yet to write their bio.Meanwhile lets just say that we are proud mercuric contributed a whooping 50 entries.
Entries by mercuric
On 29 June 2016, MErCuRIC partners from BHSCT and QUB will participate in a free public event on bowel cancer. Prof. Mark Lawler (QUB) will speak at the event, which will include patients, advocates and researchers as attendees.
‘Validation of a MEK/MET-specific NGS panel for early phase trial interrogation‘ and ‘Upregulation of the MET transcript is consistently associated with invasion and tumor budding in colorectal cancer‘ were presented at the AACR Annual Meeting on 18 Apr 2016 in New Orleans. Mariangela Russo from UNITO also presented related work (Abstract 878). Validation of a MEK/MET-specific […]
MErCuRIC partner hospital Hôpital Georges-Pompidou is hosting a Colorectal Cancer Information Day, open to the public on Tuesday 09 March. The event will include a simulation on the Da Vinci surgical robot and a Giant Colon to see what your own gut looks like! Registration is required at 01 56 09 39 82 or firstname.lastname@example.org
EUPATI (European Patients‘ Academy on Therapeutic Innovation) launched the EUPATI Toolbox today. Funded by the Innovative Medicines Initiative, EUPATI provides scientifically reliable, objective, comprehensive information to patients on medicines research and development. The Toolbox covers the A to Z of how medicines are developed. Check it out here!
MErCuRIC partners attended a successful meeting in Dublin, Ireland on 15 Jan 2016. Progress made by the consortium in year 2 was discussed and work for year 3 was planned. Our first Phase I study is drawing to a close and plans for the next Phase I work are well underway. We have also advanced the […]
MErCuRIC has been featured as a case study in the 2014- 2015 Annual Report of the Experimental Cancer Medicine Centre (ECMC) Network in the UK.
We’ve just launched a new patient area on the project website – have a look!
We’ve created a new area on the project website for publications from our partners that are relevant to MErCuRIC – check it out!
EUPATI, the European Patients’ Academy on Therapeutic Innovation has published their Oct 2015 newsletter – learn more about the experience of students who have just completed the first Patient Xpert Training Course and why regulatory agencies think patient education and engagement are important.
- ‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success StoryApril 16, 2018 - 10:46 am
- MErCuRIC study published in Molecular Cancer TherapeuticsMarch 6, 2018 - 10:14 am
- MErCuRIC team from RECETOX, Masarykova Univerzita publish study resultsMarch 5, 2018 - 9:11 am
MErCuRIC is funded by the European Community’s Framework Programme Seven (FP7) under contract #602901. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.